88 related articles for article (PubMed ID: 16425995)
1. Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.
Munson EL; Nardelli DT; Luk KH; Remington MC; Callister SM; Schell RF
Clin Vaccine Immunol; 2006 Jan; 13(1):19-25. PubMed ID: 16425995
[TBL] [Abstract][Full Text] [Related]
2. Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.
Munson EL; Du Chateau BK; Jensen JR; Callister SM; DeCoster DJ; Schell RF
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1095-101. PubMed ID: 12204965
[TBL] [Abstract][Full Text] [Related]
3. Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.
Munson EL; Du Chateau BK; Jobe DA; Lovrich SD; Callister SM; Schell RF
Infect Immun; 2000 Oct; 68(10):5496-501. PubMed ID: 10992445
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibody.
Remington MC; Munson EL; Callister SM; Molitor ML; Christopherson JA; DeCoster DJ; Lovrich SD; Schell RF
Infect Immun; 2001 Jul; 69(7):4268-75. PubMed ID: 11401963
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice.
Nardelli DT; Kevin Luk KH; Kotloski NJ; Warner TF; Torrealba JR; Callister SM; Schell RF
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):265-74. PubMed ID: 18522647
[TBL] [Abstract][Full Text] [Related]
6. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi.
Jensen JR; Du Chateau BK; Munson EL; Callister SM; Schell RF
Infect Immun; 1998 Apr; 66(4):1507-12. PubMed ID: 9529074
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.
Munson EL; DeCoster DJ; Nardelli DT; England DM; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Jan; 11(1):35-41. PubMed ID: 14715542
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.
Bockenstedt LK; Fikrig E; Barthold SW; Flavell RA; Kantor FS
J Immunol; 1996 Dec; 157(12):5496-502. PubMed ID: 8955199
[TBL] [Abstract][Full Text] [Related]
11. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes.
Knigge H; Simon MM; Meuer SC; Kramer MD; Wallich R
Eur J Immunol; 1996 Oct; 26(10):2299-303. PubMed ID: 8898937
[TBL] [Abstract][Full Text] [Related]
12. A new approach to a Lyme disease vaccine.
Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
[TBL] [Abstract][Full Text] [Related]
13. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
[TBL] [Abstract][Full Text] [Related]
14. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.
Alexopoulou L; Thomas V; Schnare M; Lobet Y; Anguita J; Schoen RT; Medzhitov R; Fikrig E; Flavell RA
Nat Med; 2002 Aug; 8(8):878-84. PubMed ID: 12091878
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
Fawcett PT; Rose CD; Budd SM; Gibney KM
Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
[TBL] [Abstract][Full Text] [Related]
16. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo.
Zhong W; Wiesmüller KH; Kramer MD; Wallich R; Simon MM
Eur J Immunol; 1996 Nov; 26(11):2749-57. PubMed ID: 8921965
[TBL] [Abstract][Full Text] [Related]
17. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
Liang FT; Caimano MJ; Radolf JD; Fikrig E
Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
[TBL] [Abstract][Full Text] [Related]
18. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.
Lovrich SD; La Fleur RL; Jobe DA; Johnson JC; Asp KE; Schell RF; Callister SM
Clin Vaccine Immunol; 2007 May; 14(5):635-7. PubMed ID: 17344346
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells.
Mbow ML; Zeidner N; Gilmore RD; Dolan M; Piesman J; Titus RG
Infect Immun; 2001 Apr; 69(4):2407-15. PubMed ID: 11254601
[TBL] [Abstract][Full Text] [Related]
20. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM
Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
